| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4295247 | Journal of the American College of Surgeons | 2008 | 8 Pages |
Abstract
Detection of micrometastatic carcinoma (N1mi) in the SLNs of invasive breast cancer patients is a major indicator of poorer survival compared with N0(iâ) patients. Although survival of patients with an N0(i+) SLN does not statistically differ from that of N0(iâ) patients, 9.3% of these patients had additional axillary nodal disease on axillary dissection, and N0(i+) patients had a decreased survival when axillary dissection was omitted.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Charles E. MD, FACS, John V. MD, Adam I. MD, FACS, John M. MD, Nathon BA, Daniel C. BS, Elisabeth L. MD, FACS, Vesna MD, Nils MD, David MS,